Hi [[ session.user.profile.firstName ]]

Forensic Science

  • Identifying Drug-Drug Interactions using PharmaPendium
    Identifying Drug-Drug Interactions using PharmaPendium Sherry Winter, PhD Recorded: May 2 2018 57 mins
    * Note the change of date*
    Learn how to identify and assess drug-drug interactions with extracted pharmacokinetic, metabolising enzyme & transporter data and a powerful Drug-Drug Interaction risk calculator
  • Searching for drug safety and benefit-risk evaluations
    Searching for drug safety and benefit-risk evaluations Dr. Jean-Dominique Pierret, Scientific Information Expert Recorded: Apr 25 2018 56 mins
    Scientific literature is one of the largest source of adverse event reports, making it an essential part of pharmacovigilance. Marketing authorization holders are expected to perform systematic literature searches using reference databases and local journals from countries where the medicinal product has a marketing authorization. The retrieved information needs to be collated, analyzed, and communicated at least once a week. However, several challenges are associated with this process. Large amounts of data from various sources, various regulatory requirements, building and maintaining search strategies increase the complexity of literature searches.

    In this webinar, Scientific Information Expert Dr. Jean-Dominique Pierret will give a brief overview of regulatory obligations and usefulness of literature in the drug development process. And then he will introduce how he set up literature search for pharmacovigilance: such as selecting the databases, building the strategy with a focus on early detection of safety issue and benefit/risk assessment. Finally, he will give examples of challenges that may occur during literature search for pharmacovigilance.

    About the speaker:
    Dr. Jean-Dominique Pierret is a Scientific Information Expert and he spent +20 years in the pharmaceutical industry. He is currently working for Galderma R&D. With a strong background in information sciences applied to the biomedical domain, he is involved in the management of a corporate scientific library, in competitive intelligence and in information retrieval. Jean-Dominique is in charge for years of the literature survey for pharmacovigilance.
  • Digital health: how can technology be used to engage hard-to-reach patients?
    Digital health: how can technology be used to engage hard-to-reach patients? Trishna Bharadia, MS patient advocate, Jo Sopala, MS Trust, Rachel Morrison, NHS Western Isles Recorded: Apr 20 2018 65 mins
    Helping someone live with a condition as complex as MS can be fraught with challenges.

    MS professionals are asked to manage multiple physical and psychological symptoms while following complicated drug monitoring regimes, all in the face of shirking resources and growing caseloads.

    As the burden of monitoring people on disease modifying therapies has grown, a corresponding lack of resource for symptom management has led to inequity of services for those with progressive disease.
    Across the UK, however, technology is being used to overcome these obstacles, by erasing geographic boundaries and expanding access.

    From conducting video consultations to setting up online peer support groups, digital health can and is being utilised to improve services for everyone.

    As part of the Quality in the Delivery of Services (QuDoS) in MS recognition programme, a panel of experts will discuss how to meet the information, support and engagement needs of people living with MS through technology.

    The live webinar, produced by pharmaphorum with the support of the MS Trust and Biogen, will feature the views of patients and professionals alike.

    The panel, which will include Jo Sopala, Director of Development at the MS Trust, will discuss using digital health to:
    -Increase patient access to quality, trusted information through digital translation services
    -Offer greater support through online peer support and symptom management apps
    -Boost adherence through electronic reminder systems
    -Increase involvement in clinical trials through wearable technologies
    -Increase access to services through remote appointments
  • Embase for Medical Affairs
    Embase for Medical Affairs Embase Product Manager: Dr. Iveta Petrova Recorded: Apr 19 2018 47 mins
    Medical affairs teams need quick direct access to the latest literature so they can rapidly respond to client inquiries from anywhere. Embase has unique and comprehensive journal and conference coverage, in-depth indexing that makes it easy to find answers and customizable e-mail alerts that send out regular updates to automate the retrieval of information. Embase specialized capabilities ensure not only comprehensive retrieval of relevant information, but also that it is done in an easy and fast way saving time and money.

    In this session, Elsevier's product manager Dr. Iveta Petrova will demonstrate how Embase can support daily tasks, including:

    - How to design a comprehensive EBM search in just a few steps
    - How to follow innovations in your subject field and related KOLs
    - How to make an indirect comparison between two drugs
    - How to identify opportunities for an investigator initiated trial

    About the speaker:
    Iveta Petrova holds a Ph.D. from Leiden University for research done on Wnt signaling in the nervous system. For the last three years, she is part of the Embase team. Main focus is addressing specific use cases of Medical Affairs professionals by leveraging the capabilities and peer-reviewed enhanced content of the biomedical database Embase, as well as continuous engagement with customers and market research to further improve and develop tools to support them in their daily responsibilities.
  • Introduction to the Education Network - EduRN
    Introduction to the Education Network - EduRN Shirley Decker-Lucke Recorded: Apr 11 2018 33 mins
    You are invited to join the Education Research Network (EduRN) – the education community’s platform for sharing early-stage research, including preprints, working papers, and data prior to publication. EduRN is powered by SSRN, the leading working paper repository and preprint server since 1994.
  • Leverage PK data in PharmaPendium to inform drug development strategies
    Leverage PK data in PharmaPendium to inform drug development strategies Sherry Winter, PhD Recorded: Mar 27 2018 48 mins
    Pharmacokinetic information from FDA and EMA regulatory documents informs translational and clinical development decisions and may lead to more successful drug development and regulatory approval strategies.

    In this webinar, we will discuss how to leverage comparative pharmacokinetic information from FDA and EMA Drug Approval documents to make better-informed decisions on which drugs have the most potential to succeed in clinical development.
  • How To Publish in High Impact Journals
    How To Publish in High Impact Journals Cell Press Editor-in-Chief Robert Eagling and Dr. Rebecca Cooney, North American Executive Editor of The Lancet Recorded: Mar 27 2018 76 mins
    Join Dr. Robert Eagling, Cell Press Editor-in-Chief of Chem, and Dr. Rebecca Cooney, North American Executive Editor of The Lancet, to learn about techniques and strategies for authoring in high-impact journals. Dr. Eagling will present information on authoring with Cell Press, which includes such titles as Cell, Neuron, Chem, Immunity, Joule, and Cancer Cell. In addition, Dr. Cooney will represent publishing in The Lancet premium medical journal portfolio.


    The editors will present their experience working with researchers and authors throughout the research publishing cycle, how to develop papers for premium publications, and the opportunity to broadly disseminate findings. You won’t want to miss this engaging webinar and how it can benefit your research process and impact.
  • Promoting Open Access Scholarship - SSRN & Bepress Digital Commons
    Promoting Open Access Scholarship - SSRN & Bepress Digital Commons Gregg Gordon Recorded: Mar 21 2018 34 mins
    Gregg Gordon, managing director at SSRN, answering questions for our RPS community about the synergies of SSRN and Bepress.
  • Finding the right information for Medical Device Clinical Evaluation and PMS
    Finding the right information for Medical Device Clinical Evaluation and PMS Embase Senior Product Manager: Dr. Ivan Krstic Recorded: Mar 21 2018 62 mins
    Information found in the biomedical literature is a significant source for every stage of the medical device life cycle, from concept and design through clinical trials to release and reimbursement, as well as post-market surveillance.

    In June 2016, the updated Medical Device Clinical Evaluation Report (CER) guidelines came into effect (Revision 4 of MEDDEV 2.7/1), detailing where and how to search for literature and how to record the process of collecting, appraising and analyzing the items found.

    In this session, Elsevier's senior product manager Dr. Ivan Krstic demonstrated how Embase is especially suited to help Medical Device manufacturers prepare CER, including:

    - How to design effective literature searches for Clinical Evaluation reports using the PICO search form in Embase;
    - How to build a more comprehensive search using Emtree terms and synonyms;
    - How trade name and manufacturer name indexing supports analyses of devices already on the market;
    - How to find mentions of adverse device reactions in the literature for effective post-market surveillance (PMS) reporting
  • UK pharma and integrated health
    UK pharma and integrated health Stephen Dorrell, NHS Confederation, James Roach, Accountable Care Partnership, Essex Andrew Smith, Cobic, Steve Jowett, IQVIA Recorded: Mar 21 2018 64 mins
    The concept of integrated healthcare is not new to the UK, where it has been discussed since the late 1960s.

    The difference is that now it could really happen. Technology, medicine, regulation and pricing have all evolved to a point where a collaborative, integrated system is not only possible, but desirable – and the data needed for it to become a reality is now available.

    What does this mean for UK pharmaceutical companies that have historically focused on providing medicines and treatments?

    On one hand there are calls for them to change – going beyond being simply a supplier of products and moving into the role of partner, sharing risk to drive great health outcomes.

    On the other hand, the industry’s move into having pipelines that are largely stocked with niche products has created pricing and access questions which are yet to be fully answered.

    Analysing the current situation and looking for potential routes to the future, this high-level IQVIA/pharmaphorum webinar gave an update on the latest developments and debated how pharma can be a catalyst for change at a time when the NHS is under immense pressure to cut costs and become more efficient.

    Insight on these pressing issues was provided by a panel of influential healthcare experts that included former secretary of state for health, and NHS Confederation current chairman, Stephen Dorrell.

    He was joined by:
    James Roach, director, Accountable Care Partnership, West Essex Health and Care System
    Andrew Smith, director, Cobic
    Steve Jowett, country lead for health system engagement, IQVIA

    Watch the digital debate to learn more about:

    The evolving NHS and the STP/ICS model of delivery
    What a collaborative future could look like
    The role of data in the future NHS
    Why the STP/ICS model is important for pharma
  • Get more from Reaxys: for Newbies & Reaxys Pros (5pm CET)
    Get more from Reaxys: for Newbies & Reaxys Pros (5pm CET) Jurgen Swienty-Busch Recorded: Mar 8 2018 65 mins
    1. Why New Reaxys in the first place
    - What did you miss in old Reaxys without knowing?
    - How to search in new Reaxys and why it is more efficient?
     Reaction searching
     Document searching
     Substance searching

    2. Whats new new?
    - Update on last release and short term roadmap outlook

    3. Where to find additional support (e.g. support center etc)
  • Get more from Reaxys: for Newbies & Reaxys Pros (9am CET)
    Get more from Reaxys: for Newbies & Reaxys Pros (9am CET) Jurgen Swienty-Busch Recorded: Mar 8 2018 64 mins
    1. Why New Reaxys in the first place
    - What did you miss in old Reaxys without knowing?
    - How to search in new Reaxys and why it is more efficient?
     Reaction searching
     Document searching
     Substance searching

    2. Whats new new?
    - Update on last release and short term roadmap outlook

    3. Where to find additional support (e.g. support center etc)
  • Systematic searching in Embase: using PICO to identify relevant results
    Systematic searching in Embase: using PICO to identify relevant results Xuanyan Xu Recorded: Mar 5 2018 64 mins
    *Rescheduled: due to the technical issues on Monday, Feb 26. The following webinar has been rescheduled to Monday, Mar 5. We appologoze for any inconvenience and welcome you to join us for the live broadcasting.*

    This is an introductionary webinar on searching the medical literature to answer clinical questions, with a focus on PICO Search Strategies.

    The PICO (Patient, Intervention, Comparator/Control, Outcome) process is a technique used in evidence-based practice to frame and answer a clinical question. The PICO framework is also used to develop literature search strategies.

    In this webinar, Embase solution marketing manager Xuanyan Xu will discuss:

    - The basics of systematic review and guideline making
    - The concepts that form a PICO search strategy
    - How to use PICO search form in Embase to build effective searches

    About Embase
    Embase is a highly versatile, multipurpose and up-to-date biomedical database. It covers the most important international biomedical literature from 1947 to the present day and all articles are indexed in depth using Elsevier's Life Science thesaurus Embase Indexing and Emtree®. The entire database is also conveniently available on multiple platforms.

    Ready to take the next step? Get started with this introductory webinar.
  • Supporting Drug Safety with PharmaPendium and advanced FAERS searching
    Supporting Drug Safety with PharmaPendium and advanced FAERS searching Sherry Winter Recorded: Feb 27 2018 59 mins
    Drug safety considerations impact the entire drug development lifecycle, from preclinical safety assessments to clinical trials to post-market.

    In this webinar, we will discuss how to leverage the comparative FDA and EMA regulatory information in PharmaPendium to inform translational and clinical development decisions, as well as to strengthen regulatory approval strategies.
  • Sharing Early-Stage Research Accelerates Advancement
    Sharing Early-Stage Research Accelerates Advancement Gregg Gordon and Shirley Decker-Lucke Recorded: Jan 11 2018 33 mins
    Introducing the Engineering Research Network (ENGRN)

    You are invited to join the Engineering Research Network (EngRN) – a platform dedicated to providing the engineering community with a place to share research prior to and during journal peer review. EngRN is powered by SSRN, which has been an established working paper and preprint server for the dissemination of early research since 1994.

    Real world problems are getting solved by researchers like you, every day.
    Sharing your research results prior to peer review can accelerate the advancement of research for everyone. SSRN has been proving this to be true in the Social Sciences and is now dedicated to fostering sharing and collaboration in the Life Sciences, Physical Sciences, and Engineering. EngRN supports early stage research sharing in engineering areas such as aerospace, bioengineering, chemical, civil, electrical, energy, industrial, manufacturing, materials, and mechanical.
  • Total Nitrogen Test Kits as an Alternative to TKN, Nitrate, and Nitrite Tests
    Total Nitrogen Test Kits as an Alternative to TKN, Nitrate, and Nitrite Tests Taylor Reynolds; Ed Askew Ph.D. Recorded: Dec 14 2017 48 mins
    Currently the US EPA has not promulgated a method for the analysis of Total Nitrogen (TN). Most states that have TN regulations require permitee's to measure TN as the composite of TKN, Nitrate and Nitrite. This approach is costly, time consuming, and also susceptible to variability based on the methods used for the individual analytes Merck, KGaA, Darmstadt, Germany is excited to announce the introduction of a Total Nitrogen Test Method consisting of a single spectrophotometric test kit. The method has been evaluated in a multilab study and this webinar will present the results of that study as well as an overview of the savings made possible by utilizing this new method for testing Total Nitrogen.
  • Rapid Fontana-Masson Staining
    Rapid Fontana-Masson Staining Vikas Palhan, PhD, Senior R&D Scientist, Emerging Biology - Genomics Recorded: Dec 14 2017 23 mins
    In the continued effort to save you time and simplify your workflow, we’ve developed a Fontana-Masson Staining Kit with a protocol that is 30x faster than the standard protocol. In this webinar, the researcher who developed the kit explains how easy it is to use this new rapid microwave technique. If you need to stain melanin and argentaffin cells in tissue sections, take a few minutes to watch this webinar - and save yourself many more minutes in the future by using this kit.
  • UNLEARN. RELEARN. REIMAGINE. Smarter communications through behavioral science
    UNLEARN. RELEARN. REIMAGINE. Smarter communications through behavioral science Andrew McConaghie, David Hogben (Complete HealthVizion), Robert Poole (Complete HealthVizion), Bjarke Ebert (Lundbeck) Recorded: Nov 22 2017 69 mins
    How can we create smarter, more effective communications for HCPs and patients? What can be done to challenge the status quo, apply a different mindset to communications, and deliver the best possible patient outcomes?

    In this webinar, we will discuss how multichannel strategy and behavioural science are natural partners in creating smarter, more meaningful, and more effective communications. The premise is simple: if we apply a behavioural mindset, we can determine where to focus our communications for the best effect, design the most appropriate multichannel strategy and content, and put the right metrics in place to measure success.
  • The Role and Limitations of Sigma Analysis in Lab QC
    The Role and Limitations of Sigma Analysis in Lab QC Jack Montgomery, MLS(ASCP)cm Recorded: Nov 15 2017 54 mins
    Hear Jack Montgomery share his experiences and methodologies in applying sigma analysis to lab quality control at Asante Health, a Truven Health Analytics Top 100 hospital the past four years.

    In this webinar, Jack will discuss the dynamic nature of sigma metrics for clinical chemistry analytes. He will show how they can be improved over time with enhanced monitoring and optimized maintenance schedules. This sensitivity of sigma metrics highlights the notion that sigma methodology is just one of the many tools that should be used for a holistic approach to lab quality.

    By attending this webinar, you will:
    - Understand the practical use of Six Sigma as a lab quality tool
    - Learn about the dynamic nature of sigma metrics and how they can be improved in the lab
    - Gain insights into the additional tools for implementing a multi-faceted total quality program

    P.A.C.E. credit is available for your participation.*

    Presenter:
    Jack Montgomery, MLS(ASCP)cm, is the chemistry technical specialist for Rogue Regional Medical Center—the flagship entity for Asante Health—a growing three-hospital system located in southern Oregon containing a laboratory accredited by the College of American Pathologists. Jack has over 40 years of experience in the clinical laboratory with a special interest in quality control, sigma metrics and method validation.

    *Beckman Coulter, Inc. is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E® Program. These credits are recognized by the State of California. Most programs also provide State of Florida credits (with valid license number). At this time we cannot issue continuing education credits for those who provide healthcare (or work for an institution that provides healthcare) in Massachusetts or Vermont.
  • GDPR - Responding to a breach in a Timely Manner
    GDPR - Responding to a breach in a Timely Manner Mike Smart - Forcepoint, Chris Jones - Forcepoint Recorded: Nov 10 2017 47 mins
    Organizations will need to rapidly detect data incidents and efficiently orchestrate the appropriate response within the 72 hour breach response window. In this session, Forcepoint explores how technologies can support an organization’s breach response process.
  • Rethinking Data Security in a Zero Perimeter World
    Rethinking Data Security in a Zero Perimeter World Eric Ogren 451 Research and Bharath Vasudevan Forcepoint Recorded: Nov 8 2017 58 mins
    IT’s desire to become more nimble and agile has resulted in the rapid adoption of cloud delivered applications. This is not limited to the heavy hitters like salesforce.com for CRM or Office 365 for productivity. There are also applications servicing tasks and functions organizations might choose to outsource. The result is critical data spread across a vast array of resources, both on and off premise. Many organizations may use built-in cloud security functionality on top of their individual legacy deployments. However, this leads to silos of capability, mismatched policies, and noise in the form of alerts needing to be addressed.

    Join Forcepoint and 451 Research as we address how taking a human-centric, risk adaptive approach can transform data security programs.
  • Women's & Gender Studies Webcast - Share Your Ideas. Change The World.
    Women's & Gender Studies Webcast - Share Your Ideas. Change The World. Join Live Webcast with Gregg Gordon & Shirley Decker-Lucke Recorded: Nov 2 2017 32 mins
    You are invited to join WGSRN – the Women's & Gender Studies research network that facilitates discovery, collaboration, and sharing of early stage research across interdisciplinary sciences.

    WGSRN is a working paper and preprint server. It is powered by the SSRN platform, which has been helping researchers share their results since 1994.

    With thirty plus networks providing classified, organized working papers, and preprints for free, SSRN supports interdisciplinary discovery, collaboration, and sharing. Posting your work prior to peer review can accelerate the advancement of Women's & Gender ideas and research. Plus, it can help enhance your reputation as a researcher.

    Gregg is the managing director at SSRN focused on the high quality, rapid, electronic dissemination of scholarly research at the lowest possible cost - Tomorrow's Research Today.

    Shirley Decker-lucke is the publishing director at SSRN and joins Gregg’s mission in creating the new, new research for early discovery, collaboration, and sharing.

    In May 2016, SSRN joined Elsevier, a world-leading provider of information solutions promoting the performance of science, health, and technology professionals, empowering them to make better decisions, and deliver better care. Together, we can further enhance early discoveries of ideas in an open-access environment of sharing and collaboration.
  • Navigator 3.0: taking channel insights to the next level
    Navigator 3.0: taking channel insights to the next level Ruud Kooi (Managing Partner, Across Health) and Philip Baciaz (VP Customer Insights, Across Health) Recorded: Oct 25 2017 48 mins
    Knowing the “right channel” (combination) is just one (key) part of a customer-centric omnichannel strategy. Including other critical dimensions - notably “right content”, “right context”, and “right frequency” – has never been easy. And mapping these onto who the right customer is, and how to benchmark your competition in markets, is a challenge that is only growing.

    The Across Health Navigator 3.0 delivers easily navigable insights into all of these components – as well as giving a thorough survey of the third party media which physicians in different specialties and markets use. This final component allows a solid basis for evaluating websites, newsletters, apps, congresses, and online communities.

    In this webinar, we will talk about:

    - What are the key metrics for customer engagement: right channel, right context, and right frequency
    - What channel insights can do for omnichannel campaigns in terms of right content
    - How to benchmark your competitors in different TAs and territories
    - Evaluating the reach and impact of different third party media
  • Automation of the in vitro micronucleus assay using imaging flow cytometry
    Automation of the in vitro micronucleus assay using imaging flow cytometry Matthew. A Rodrigues, PhD., Research Scientist with Amnis-Merck KGaA, Darmstadt, Germany Recorded: Oct 24 2017 57 mins
    The in vitro micronucleus assay is one of the most widely used tests to quantify genotoxicity and cytotoxicity, especially as a screening tool in the development of chemicals and pharmaceuticals. Micronuclei (MN) are formed from whole chromosomes or chromosome fragments that lag behind during the metaphase-anaphase transition and are excluded from the main nucleus following division. MN form into small, rounded bodies surrounded by their own nuclear envelope and represent chromosomal mutations that can be used as an endpoint in genotoxicity testing. Typically performed by manual microscopy, the MN assay is laborious and can be subject to scorer bias. To overcome this, automated microscopy and conventional flow cytometry methods have been developed. However, these methods suffer from several limitations such as the requirement to create high quality slides in the case of microscopy and the lack of visual confirmation of MN in the case of flow cytometry. The ImageStream®X (ISX) imaging flow cytometer has the potential to overcome these limitations as it combines the speed, statistical robustness and rare event capture capability of conventional flow cytometry with high resolution fluorescent imagery.
    In this webinar, adaptation of the in vitro MN assay to an imaging flow cytometry-based method will be described. Using the ISX Mark II imaging flow cytometer, images of micronucleated mono- and binucleated cells as well as polynucleated cells can be captured at a high flow rate and automatically identified and scored in the Image Data Exploration and Analysis Software (IDEAS®) that accompanies the ISX. A data analysis template created specifically for this application allows for the determination of both genotoxicity and cytotoxicity following treatment with known clastogens and aneugens. This work is the first demonstration of fully automated method for performing the in vitro MN assay on an imaging flow cytometry platform.
  • The Global Impact of GDPR
    The Global Impact of GDPR Eduardo Ustaran - Hogan Lovells, Neil Thacker - Forcepoint Recorded: Oct 12 2017 64 mins
    A discussion on the Global implications of GDPR, with Hogan Lovells

    Join Hogan Lovells' Privacy and Data Protection Lawyer, Eduardo Ustaran and Forcepoint Deputy CISO Neil Thacker for a live webcast, as they discuss the global implications of the General Data Protection Regulation (GDPR).

    Whilst awareness of the GDPR is increasing, the broader impact is still misunderstood: any Global organization that holds or processes EU resident data will be subject to the regulation.

    In this webcast, they will discuss:

    - Which key principles of the GDPR regulation widely affect organizations
    - How prepared global organizations are to meet the May 2018 deadline
    - The latest information and guidance from the Article 29 Data Protection Working Party
    - What can be learned from organizations who are at an advanced stage in their GDPR preparations
    - The positive return to the organization from undertaking a GDPR readiness program
  • Reducing efficacy-related failures with PharmaPendium
    Reducing efficacy-related failures with PharmaPendium Sherry Winter, PhD May 22 2018 2:00 pm UTC 60 mins
    Join us for this 45-minute webinar that will include in-depth information and demonstrations of how to leverage the comparative data in PharmaPendium to reduce the risk of late-stage failures. With a focus on efficacy, we will discuss how PharmaPendium enables you to:

    •find efficacy weaknesses early,
    •identify the most appropriate preclinical models,
    •improve success rates of Phase I and II clinical trial designs by optimising selection of sample size,
    •primary/secondary endpoint and study design and
    •prepare for more effective regulatory reviews
  • Shine a Spotlight on your Institutional Research
    Shine a Spotlight on your Institutional Research Thought Leader - Traci Grodner May 22 2018 3:00 pm UTC 45 mins
    If you are a researcher, a department dean at a prestigious university or a librarian looking for research tools to help researcher and faculty members save time and create new research faster; you won't want to miss this informative webcast. We invite you to join us on May 22 at 11:00a.m. EDT for our live webcast.

    With research influencing accreditation policies and overall student engagement, now is the time to accelerate your institution's data management plan. When it comes to managing scholarly research, there's a lot that goes into data collection, preservation, and idea sharing.

    Early-Stage Scholarly Research Gets Your Institution in the Spotlight: an introduction to early-stage scholarly research and the value of showcasing your researchers' fundamental ideas, concepts, working papers, in an open-sharing environment while increasing readership of your institution's and/or department's overall community engagement.
    You'll be pleased you tuned-in!
  • Custom Assay Development and Services utilizing Single Molecule Counting (SMC™)
    Custom Assay Development and Services utilizing Single Molecule Counting (SMC™) Sarah Hamren, Head of Custom Assays & Sample Testing, Merck KGaA, Darmstadt, Germany May 23 2018 2:00 pm UTC 75 mins
    Single molecule counting (SMC™) technology enables precise measurement of molecules at levels previously undetectable, down to the femtogram/mL levels, allowing researchers to identify new biomarkers, or assist in therapeutic development with an improved view of efficacy, safety & time course studies. When time and resources are limited, Merck KGaA offers a comprehensive portfolio of Custom Services supported by a scientific team with core expertise in SMC™ technology. Learn how our team will partner with you to develop a project specific to your requirements, whether that is fit-for-purpose sample testing, biomarker analysis using our current SMC™ immunoassays, or development and manufacture of an immunoassay for your novel target of interest. Learn how we work with our clients to define and tailor a customized project plan that includes milestone driven tasks, collaborative data review and progress reports. Whether your focus is to expedite your clinical research or to transfer a method to a CRO, we will show you how our services can help you accelerate programs from discovery into clinical trials.
  • Systematic searching with Emtree
    Systematic searching with Emtree Embase Customer Care Representative: Dr. Josephine Zimmermann May 23 2018 2:00 pm UTC 60 mins
    Embase wouldn’t be Embase without Emtree, the life science thesaurus is a hierarchically structured, controlled vocabulary, for Biomedicine and related Life Sciences, providing a consistent description for Embase indexing.

    - It offers indexers a comprehensive vocabulary to describe the content of biomedical data;
    - For database users, it facilitates comprehensive searching and high precision retrieval.

    Emtree has been used to index Embase (including Embase Classic) since 1947, and is unrivalled in its coverage of drug and medical terminology.

    In this webinar, Embase Customer Care Representative Dr. Josephine Zimmermann will walk you through:

    - How Emtree is built-up and managed
    - How we index a typical article
    - How drugs, diseases and devices are indexed in Embase

    About the speaker:
    Josephine Zimmermann holds a PhD in Molecular and Structural Chemistry and Physics from University of Grenoble for her research on the synthesis of fluorescent core-shell nanoparticles for medical imaging. Since two years, she works as Customer Care Representative at Elsevier and supports Embase as well as other Life Science Products. She is reporting the voice of the customer by collaborating closely with the Embase team, analyzing tendencies, providing feedback, and helping you with any kind of issues.
  • Custom Assay Development & Services utilizing Single Molecule Counting (SMC™)2
    Custom Assay Development & Services utilizing Single Molecule Counting (SMC™)2 Sarah Hamren, Head of Custom Assays & Sample Testing, Merck KGaA, Darmstadt, Germany May 24 2018 12:30 am UTC 75 mins
    Single molecule counting (SMC™) technology enables precise measurement of molecules at levels previously undetectable, down to the femtogram/mL levels, allowing researchers to identify new biomarkers, or assist in therapeutic development with an improved view of efficacy, safety & time course studies. When time and resources are limited, Merck KGaA offers a comprehensive portfolio of Custom Services supported by a scientific team with core expertise in SMC™ technology. Learn how our team will partner with you to develop a project specific to your requirements, whether that is fit-for-purpose sample testing, biomarker analysis using our current SMC™ immunoassays, or development and manufacture of an immunoassay for your novel target of interest. Learn how we work with our clients to define and tailor a customized project plan that includes milestone driven tasks, collaborative data review and progress reports. Whether your focus is to expedite your clinical research or to transfer a method to a CRO, we will show you how our services can help you accelerate programs from discovery into clinical trials.
  • Engaging with HCPS: what do HCPs want from medical meetings?
    Engaging with HCPS: what do HCPs want from medical meetings? Aoife Delmas, European Society of Cardiology, Katie Koziol and Andrew Moore, Ashfield Meetings & Events Jun 26 2018 2:00 pm UTC 75 mins
    There has been a myriad of reasons over the past few years to safely assume the popularity and perceived worth of face-to-face medical meetings was well and truly on the decline – from advances in technology, to funding challenges.

    Yet a 2018 study by Ashfield looking at global HCP preferences reveals that the medical meeting is in fact their preferred channel for scientific communications.

    Furthermore, HCPs exhibit consumer behaviours in selecting and attending events – which means that while these conferences offer potential engagement riches, they have to offer a specific mix of focus, value and ROI to be successful. To analyse this situation, discuss the learnings from the research and offer guidance on what a modern medical meeting needs to be we present an exclusive debate.

    Bringing together experts from (TBC) our panel will discuss:

    1. Findings from the 2018 Ashfield Science of HCP Meetings research and whitepaper
    2. How HCPs want to engage with pharma and scientific communications
    3. What works? How to create the events that HCPs want to attend
    4. The future of meetings - balancing face to face and digital
    5. How HCPs determine whether a meeting is likely to be worth the investment
    6. Strategies and tactics for planners and meeting stakeholders to implement to continue to add value for HCPs attending medical meetings